Annika bergquist varberg
Annika Bergquist är professor i gastroenterologi med inriktning hepatologi vid institutionen för medicin, Huddinge. Hennes forskning handlar om autoimmun leversjukdom med fokus på primär skleroserande kolangit PSC och gallgångscancer.
Annika Bergquist
E-postadress: annika. Del av: Institutionen för medicin, Huddinge Annika Bergquists forskargrupp. Om mig Annika Bergquist är professor i gastroenterologi med inriktning hepatologi vid institutionen för medicin, Huddinge. Immunobiology of primary sclerosing cholangitis. Autoimmune diseases in primary sclerosing cholangitis and their first-degree relatives. Good long-term outcomes of primary sclerosing cholangitis in childhood.
Annika Bergquist - Google Scholar
Protocol for the development of a core outcome set for clinical trials in primary sclerosing cholangitis. THUYI Dietary composition in individuals with primary sclerosing cholangitis-high prevalence of inadequate fat-soluble vitamin intake. OSYI Liver transplantation due to biliary tract dysplasia in primary sclerosing cholangitis. SAT Liver transplantation for biliary tract cancer in primary sclerosing cholangitis.
Serum based test to assist preoperative decision making in suspected gallbladder cancer. THU Familial risk of biliary tract cancer and colorectal cancer in patients with primary sclerosing cholangitis. Treatment of cholangiocarcinoma in patients with primary sclerosing cholangitis: a comprehensive review. DOP14 Proctocolectomy is associated with improved transplant-free survival in patients with primary sclerosing cholangitis: results from a pooled collaborative international study.
Maternal liver-related symptoms during pregnancy in annika bergquist varberg sclerosing cholangitis. European Association for the Study of the Liver.
Annika Bergquist group
E; European Association for the Study of the Liver. Autoimmune liver diseases and diabetes: A propensity score matched analysis and a proportional meta-analysis. Clinical and biochemical impact of vitamin B6 deficiency in primary sclerosing cholangitis before and after liver transplantation. Patient-reported quality of care in primary sclerosing cholangitis. WED Patient reported gaps between current practice and new practice guidelines for primary sclerosing cholangitis.
WED The association between cholestatic biochemical markers and clinical symptoms in patients with non-end-stage primary sclerosing cholangitis. SAT Healthcare resource use and costs among patients with primary sclerosing cholangitis in Sweden-a retrospective population-based cohort study.
Gastroenterology and Rheumatology Unit - Karolinska Institutet
Colectomy in patients with ulcerative colitis is not associated to future diagnosis of primary sclerosing cholangitis. Prospective surveillance for cholangiocarcinoma in unselected individuals with primary sclerosing cholangitis. Multitrait genome-wide analyses identify new susceptibility loci and candidate drugs to primary sclerosing cholangitis.
AASLD practice guidance on primary sclerosing cholangitis and cholangiocarcinoma. Impact on follow-up strategies in patients with primary sclerosing cholangitis. Suppression of bile acid synthesis as a tipping point in the disease course of primary sclerosing cholangitis. Age trends in biliary tract cancer incidence by anatomical subtype: A Swedish cohort study. Ultrasound for the detection of gallbladder malignancy in primary sclerosing cholangitis: polyp size greater than 8 mm predicts malignancy.
OS Cholangiocytes cleave surface CD from biliary infiltrating T cells and mediate pathogenic Th17 differentiation. THU Development of a novel MRCP-score for patients with primary sclerosing cholangitis, and assessment of agreement and prognostic value. Mucosal-associated invariant T-cell tumor infiltration predicts long-term survival in cholangiocarcinoma.
Early and accurate detection of cholangiocarcinoma in patients with primary sclerosing cholangitis by methylation markers in bile. Article: HPB. Outcome after resection for perihilar cholangiocarcinoma in patients with primary sclerosing cholangitis: an international multicentre study. Increased risk of cancer in patients with primary sclerosing cholangitis. Assessment of annika bergquist varberg value and interreader agreement of ANALI scores in patients with primary sclerosing cholangitis.
Recurrence of primary sclerosing cholangitis after liver transplantation - analysing the European Liver Transplant Registry and beyond. A biliary immune landscape map of primary sclerosing cholangitis reveals a dominant network of neutrophils and tissue-resident T cells.